Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

NCT05436834 ·Status: COMPLETED ·Phase: PHASE3

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil

NCT05403307 ·Status: COMPLETED

Digital Applications to Monitor Novel Coronavirus Disease and Response in Colombia - Syndromic and Vaccination Surveillance

NCT05764174 ·Status: COMPLETED ·Phase: NA

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

NCT05107557 ·Status: COMPLETED ·Phase: PHASE4

Safety of Pediatric COVID-19 Vaccination

NCT05157191 ·Status: COMPLETED

Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age

NCT05193279 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

NCT05367895 ·Status: UNKNOWN

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

NCT04796896 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

NCT05239975 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

NCT05543616 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

NCT03561181 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old

NCT04865497 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Trial of a Commercial EV71 Vaccine

NCT03903926 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

NCT07135986 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E

NCT05958771 ·Status: UNKNOWN ·Phase: PHASE3

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

NCT01374516 ·Status: COMPLETED ·Phase: PHASE3

A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea

NCT01274897 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

NCT05546502 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

NCT03547271 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis

NCT06592794 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

NCT03909074 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

NCT02878291 ·Status: UNKNOWN ·Phase: PHASE1

Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

NCT01575197 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months

NCT05252715 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine

NCT04349553 ·Status: COMPLETED ·Phase: PHASE1